These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11495618)
21. Invasive meningococcal disease in adolescents and young adults. Harrison LH; Pass MA; Mendelsohn AB; Egri M; Rosenstein NE; Bustamante A; Razeq J; Roche JC JAMA; 2001 Aug; 286(6):694-9. PubMed ID: 11495619 [TBL] [Abstract][Full Text] [Related]
22. School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. Zangwill KM; Schuchat A; Riedo FX; Pinner RW; Koo DT; Reeves MW; Wenger JD JAMA; 1997 Feb; 277(5):389-95. PubMed ID: 9010171 [TBL] [Abstract][Full Text] [Related]
23. Meningococcal meningitis prevention programs for college students: a review of the literature. Butler KM Worldviews Evid Based Nurs; 2006; 3(4):185-93. PubMed ID: 17177931 [TBL] [Abstract][Full Text] [Related]
24. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. de Moraes JC; Perkins BA; Camargo MC; Hidalgo NT; Barbosa HA; Sacchi CT; Landgraf IM; Gattas VL; Vasconcelos Hde G Lancet; 1992 Oct; 340(8827):1074-8. PubMed ID: 1357461 [TBL] [Abstract][Full Text] [Related]
25. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880 [TBL] [Abstract][Full Text] [Related]
26. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Jackson LA; Schuchat A; Gorsky RD; Wenger JD Am J Public Health; 1995 Jun; 85(6):843-5. PubMed ID: 7762722 [TBL] [Abstract][Full Text] [Related]
27. Meningococcal carriage among Georgia and Maryland high school students. Harrison LH; Shutt KA; Arnold KE; Stern EJ; Pondo T; Kiehlbauch JA; Myers RA; Hollick RA; Schmink S; Vello M; Stephens DS; Messonnier NE; Mayer LW; Clark TA J Infect Dis; 2015 Jun; 211(11):1761-8. PubMed ID: 25505298 [TBL] [Abstract][Full Text] [Related]
28. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Mandal S; Wu HM; MacNeil JR; Machesky K; Garcia J; Plikaytis BD; Quinn K; King L; Schmink SE; Wang X; Mayer LW; Clark TA; Gaskell JR; Messonnier NE; DiOrio M; Cohn AC Clin Infect Dis; 2013 Aug; 57(3):344-8. PubMed ID: 23595832 [TBL] [Abstract][Full Text] [Related]
29. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention. Atkinson B; Gandhi A; Balmer P Pharmacotherapy; 2016 Aug; 36(8):880-92. PubMed ID: 27332671 [TBL] [Abstract][Full Text] [Related]
30. Prevention of meningococcal disease. Kimmel SR Am Fam Physician; 2005 Nov; 72(10):2049-56. PubMed ID: 16342836 [TBL] [Abstract][Full Text] [Related]
31. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment. Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749 [TBL] [Abstract][Full Text] [Related]
32. Understanding Factors Affecting University A Students' Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine. Breakwell L; Vogt TM; Fleming D; Ferris M; Briere E; Cohn A; Liang JL J Adolesc Health; 2016 Oct; 59(4):457-64. PubMed ID: 27523976 [TBL] [Abstract][Full Text] [Related]
33. Predictors of meningococcal vaccination among university students. D'Heilly S; Ehlinger E; Nichol K J Am Coll Health; 2006; 55(3):169-73. PubMed ID: 17175903 [TBL] [Abstract][Full Text] [Related]
35. Toward control of meningococcal disease: reducing risk in college students. Wenger J JAMA; 2001 Aug; 286(6):720-1. PubMed ID: 11495624 [No Abstract] [Full Text] [Related]
36. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination. van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167 [TBL] [Abstract][Full Text] [Related]
37. Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015. Soeters HM; McNamara LA; Whaley M; Wang X; Alexander-Scott N; Kanadanian KV; Kelleher CM; MacNeil J; Martin SW; Raines N; Sears S; Vanner C; Vuong J; Bandy U; Sicard K; Patel M; MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):606-7. PubMed ID: 26068563 [TBL] [Abstract][Full Text] [Related]
38. Meningococcal vaccine for adolescents and college freshmen. FDA Consum; 2005; 39(5):4. PubMed ID: 16421984 [No Abstract] [Full Text] [Related]
39. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec. De Wals P; De Serres G; Niyonsenga T JAMA; 2001 Jan; 285(2):177-81. PubMed ID: 11176810 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine. De Wals P; Deceuninck G; Boulianne N; De Serres G JAMA; 2004 Nov; 292(20):2491-4. PubMed ID: 15562128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]